In summary, the current study provides comprehensive analysis of super-enhancer-mediated transcriptional dysregulation of Ewing sarcoma, and identifies MEIS1 as a novel super-enhancer-driven oncogene, which co-operates with EWS-FLI1 in transcriptional regulation. Here, MEIS1 is linked to Ewing sarcoma.